breast cancer
Pharma Technology Focus – Issue 75
Pharma Technology Focus is now available on all devices. Read it for free here. Researchers from the University of Toronto have…
FDA approves expanded indication for Novartis drug Kisqali
Novartis has obtained approval from the US Food and Drug Administration (FDA) for its Kisqali (ribociclib) to treat hormone-receptor positive,…
UK study finds triple therapy can prevent breast cancer relapse
A new study by The Institute of Cancer Research, London, has revealed that use of triple therapy, rather than single…
